Administration of which drug is likely to block the release of the influenza virus from infected epithelial cells?

• A. Antibiotics
• B. Neuraminidase inhibitors
• C. Protease inhibitors
• D. RNA polymerase inhibitors

Answer: (B)

Neuraminidase inhibitors play a critical role in the treatment of influenza by specifically targeting the neuraminidase enzyme, which is found on the surface of the influenza virus. This enzyme is essential for the virus's lifecycle, as it facilitates the release of new viral particles from infected host cells. By inhibiting neuraminidase, these drugs prevent the virus from cleaving sialic acid residues that would otherwise allow the viral particles to detach from the epithelial cells lining the respiratory tract. As a result, the neuraminidase inhibitors effectively restrict viral spread and replication within the host, aiding the immune response in clearing the infection.

The presence of other choices highlights their ineffectiveness in blocking the release of the influenza virus. Antibiotics, for example, target bacterial infections and do not have any impact on viral pathogens like influenza. Protease inhibitors are typically used in treating viral infections such as HIV by inhibiting the processing of viral proteins, but they do not affect the influenza virus directly. RNA polymerase inhibitors would interfere with the replication of the viral RNA, but they do not specifically target the release of viral particles from infection sites. Thus, the unique action of neuraminidase inhibitors firmly establishes them as the appropriate choice for blocking influenza